Multiple Sclerosis: symptoms and treatment, Luxembourg

A young adult's disease, often unrecognised before diagnosis

Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system: the immune system mistakenly attacks the protective sheath around nerve fibres, disrupting how messages travel between the brain and the rest of the body. It's most often diagnosed between the ages of 20 and 40, and more frequently in women, making it one of the leading causes of neurological disability in young adults. Diagnosis and follow-up are handled by a neurologist, the only specialist who can confirm the disease and offer suitable treatment.

Recognising a flare-up

The first signs often catch people off guard because they can involve very different functions depending on which part of the nervous system is affected. Vision loss in one eye, sometimes with pain on eye movement, is a common way the disease first appears. Tingling, numbness or an electric-shock sensation running down the spine when bending the head forward are other common signs. Weakness in a leg, balance problems, or fatigue that's unusual and out of proportion round out the possible picture. What defines a flare-up (or relapse) is new symptoms appearing, or a clear worsening of existing ones, lasting at least 24 hours without fever or infection. Any symptoms of this kind are worth seeing a doctor about, rather than waiting for them to get worse.

Diagnosis: a process that takes time

There's no single test that confirms MS on its own. The neurologist relies on the history of symptoms, a detailed clinical examination, an MRI scan of the brain and spinal cord, and sometimes a lumbar puncture or further tests to rule out other possible causes. This process, sometimes taking several months, can be a source of anxiety; talking openly about it with the neurologist helps make it more bearable.

Disease-modifying treatments have changed the picture

For a long time, MS was synonymous with unpredictable progression and inevitable, worsening disability. That's no longer the case: several classes of disease-modifying treatment, given orally, by injection or by infusion depending on the case, clearly reduce how often flare-ups occur and slow disability progression in many forms of the disease. The choice of treatment depends on the type of MS, how active it is, and each patient's profile, and is reassessed regularly with the neurologist. Treatments for the flare-up itself, distinct from the disease-modifying treatment, can also shorten how long it lasts.

Living with the disease

Between flare-ups, many people with MS lead a full professional, family and social life, particularly when the disease is managed early. Fatigue, often underestimated by those around them, remains one of the most limiting day-to-day symptoms and is worth raising openly with the care team. Physiotherapy, occupational therapy or psychological support usefully complement medication depending on individual needs — not options reserved only for severe forms. Diet and exercise don't cure MS, but staying physically active within one's limits, not smoking, and generally healthy habits are consistently linked to a better quality of life alongside treatment, which is worth discussing with the care team rather than dismissing as secondary. Heat sensitivity is also common: a hot bath, a fever or hot weather can temporarily worsen existing symptoms without this meaning a genuine flare-up, and symptoms usually settle again once body temperature returns to normal.

The different forms of the disease

MS doesn't look the same in every patient. The most common form at the start, called "relapsing-remitting", alternates flare-ups with periods of more or less complete recovery, sometimes for years. In some patients, the disease then moves into what's called a "secondary progressive" form, with steadier worsening and fewer clearly identifiable flare-ups. A rarer form, "primary progressive", is marked by steady worsening from the outset, without distinct flare-ups. This isn't just a technical distinction: it directly shapes the choice and intensity of disease-modifying treatment, which is exactly why the neurologist reassesses it regularly throughout follow-up.

Neurology follow-up in Luxembourg

Regular follow-up with a neurologist allows the disease-modifying treatment to be adjusted, its effectiveness monitored with periodic MRI scans, and day-to-day questions addressed. Consultations, MRI scans and disease-modifying treatments are covered by the Caisse nationale de santé under the usual reimbursement rules; details are available at cns.lu. Doctipro helps you find a neurologist in Luxembourg and book an appointment online.